Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl-peptidase-4”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Post-approval studies (Phase 4)UnknownNCT02528019
What this trial is testing

Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

Who this might be right for
Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications
Kurume University 100
Testing effectiveness (Phase 2)Study completedNCT02127047
What this trial is testing

Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus Type 1
University Hospital, Basel, Switzerland 24
Early research (Phase 1)Study completedNCT05266404
What this trial is testing

Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components

Who this might be right for
Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
AstraZeneca 46
Testing effectiveness (Phase 2)Ended earlyNCT00947011
What this trial is testing

Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)

Who this might be right for
Glucose Homeostasis
Johns Hopkins University 12
Post-approval studies (Phase 4)Temporarily pausedNCT01527747
What this trial is testing

Effects of DPP-4 Inhibition on Triglycerides

Who this might be right for
Type 2 DiabetesHypertriglyceridemia
Oregon Health and Science University 15
Not applicableStudy completedNCT03081676
What this trial is testing

The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea

Who this might be right for
Maturity-Onset Diabetes of the Young, Type 3
University Hospital, Gentofte, Copenhagen 20
Post-approval studies (Phase 4)Study completedNCT01859793
What this trial is testing

Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy

Who this might be right for
DiabetesAtherosclerosis
Medical College of Wisconsin 38
Post-approval studies (Phase 4)Study completedNCT02312427
What this trial is testing

DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure

Who this might be right for
Heart FailureDiabetes Mellitus
Mitsui Memorial Hospital 10
Early research (Phase 1)Study completedNCT02749032
What this trial is testing

Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion

Who this might be right for
Type 2 Diabetes
Michael A. Nauck 24
Post-approval studies (Phase 4)UnknownNCT03458715
What this trial is testing

The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin

Who this might be right for
Type2 Diabetes
Mackay Memorial Hospital 120
Large-scale testing (Phase 3)Ended earlyNCT04371978
What this trial is testing

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

Who this might be right for
COVID 19CoronavirusDiabetes Mellitus, Type 2+12 more
Rabin Medical Center 64
Post-approval studies (Phase 4)Study completedNCT02106104
What this trial is testing

Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Amsterdam UMC, location VUmc 48
Not applicableStudy completedNCT01272583
What this trial is testing

Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery

Who this might be right for
Type 1 DiabetesHypoglycemia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 16
Post-approval studies (Phase 4)Looking for participantsNCT06972732
What this trial is testing

A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Boryung Pharmaceutical Co., Ltd 204
Large-scale testing (Phase 3)Ended earlyNCT02411084
What this trial is testing

Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD

Who this might be right for
Graft vs Host Disease
Adienne SA 36
Large-scale testing (Phase 3)Study completedNCT02104804
What this trial is testing

Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 953
Large-scale testing (Phase 3)Study completedNCT03351478
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 770
Post-approval studies (Phase 4)Study completedNCT01863147
What this trial is testing

Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease

Who this might be right for
Newly Diagnosed Type 2 DiabetesCoronary Artery Disease
Wuhan General Hospital of Guangzhou Military Command 66
Post-approval studies (Phase 4)Study completedNCT00885638
What this trial is testing

Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion

Who this might be right for
HealthyType 2 Diabetes
Lund University 12
Large-scale testing (Phase 3)Study completedNCT01093651
What this trial is testing

Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV

Who this might be right for
DiabetesInsulin Resistance
Washington University School of Medicine 20
Load More Results